Prevnar

Type: Product
Name: Prevnar
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Acip Votes to Recommend Pcv13 for Adults Aged 65 Years and Older

WASHINGTON, DC -- The following information was released by the American Pharmacists Association (APhA):ACIP holds interim meeting August 13An interim Advisory Committee on Immunization Practices (ACIP) meeting was held via Web/telephone conference on ... [Published HighBeam Research - 17 hours ago]
First reported 21 hours ago - Updated 20 hours ago - 1 reports

Does Pfizer still need AstraZeneca's vaccines business?

Pfizer CEO Ian ReadEarlier this year, when Pfizer ($PFE) made a play for rival pharma giant AstraZeneca ($AZN), CEO Ian Read listed the British drugmaker's vaccines portfolio as a motivating factor. Now, rumors are swirling that the company could be eyeing ... [Published FierceVaccines - 21 hours ago]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

Pfizer receives EMA acceptance for expanded indication of pneumonia vaccine

Pfizer Inc. has received the European Medicines Agency, or EMA, acceptance for its application seeking to expand the indication of Prevenar 13, or pneumococcal polysaccharide conjugate vaccine 13-valent, in adults to include the prevention of pneumonia ... [Published Individual.com - Aug 23 2014]
First reported Aug 22 2014 - Updated Aug 23 2014 - 1 reports

Pertussis vaccination rates unchanged after epidemic

Recent data show no increase in pertussis vaccination rates occurred following the 2011-2012 pertussis outbreak in Washington State.Elizabeth R. Wolf, MD, MPH, of the Seattle Children’s Research Institute in Seattle, and colleagues compared the proportion ... [Published Orthopedics Today - Aug 22 2014]
Entities: Epidemic, Pertussis, Vaccine
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

ACIP Backs Prevnar 13 for Seniors

(MedPage Today) -- A conjugate vaccine against pneumococcus should be routinely used by people 65 and older, the CDC's Advisory Committee on Immunization Practices has recommended. ... [Published MedPageToday.com - medical news plus CME for ph ... - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 15 2014 - 8 reports

US panel backs pneumococcal vaccines for seniors

Pneumococcal vaccines made by Pfizer and Merck & Co should be routinely offered to adults aged over 65 to prevent community-acquired pneumonia, according to a US advisory panel.The Advisory Committee on Immunization Practices (ACIP) decision places Pfizer's ... [Published PMLive - Aug 15 2014]
Entities: Vaccine, Prevnar, Pneumovax
First reported Aug 13 2014 - Updated Aug 14 2014 - 15 reports

Pfizer, Merck, pick up hefty vax sales bump with CDC nod in seniors

Pfizer's ($PFE) Prevnar 13, the world's best-selling vaccine, scored a big win Wednesday, nabbing a CDC committee nod for universal use in adults over the age of 65. And once payer coverage kicks in, that's a nod that could be worth $2 billion for Pfizer, ... [Published FiercePharma - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

EU mulls new Prevnar 13 indication

Hires and promotions for manufacturers and agenciesThe Scottish Medicines Consortium gave a thumb's down to GSK's drug and a Boehringer COPD drug.A group of investors has drawn up a list of business principles which includes not disparaging biosimilars ... [Published Medical Marketing And Media - Aug 12 2014]
First reported Aug 08 2014 - Updated Aug 09 2014 - 2 reports

EMA accepts Pfizer's application seeking new indication for Prevenar 13 for prevention of pneumococcal pneumonia in adults

The European Medicines Agency (EMA) has accepted Pfizer’s application seeking to expand the indication for Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults to include the prevention of pneumonia caused by the ... [Published PharmaBiz - Aug 09 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 7 reports

Pfizer applies for EU approval of new Prevenar 13 indication

:14 in Pharmaceutical Company Product News Pfizer has applied to the European Medicines Agency for approval of its vaccine product Prevenar 13 in a new indication. The company is seeking to expand the label of the pneumococcal polysaccharide conjugate ... [Published Zenopa - Aug 08 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 2 reports

Research and analysis: Pneumococcal disease: cases caused by strains covered by Prevenar 7 vaccine

This document contains 3 graphs showing cumulative weekly reports of invasive pneumococcal disease due to any of the 7 serotypes in Prevenar 7™ vaccine.Data covers these age groups:under 2s aged 2 to 4 years aged 5 or overData is:from June 2005 to now ... [Published Skills Funding Agency - Aug 07 2014]
Entities: Prevnar, Vaccine, Wales
First reported Jul 30 2014 - Updated Jul 31 2014 - 3 reports

Booster Shots: Pfizer Acquiring Two Baxter Vaccines for $635M

Pfizer agreed to acquire Baxter International’s two vaccines commercially marketed outside the U.S., and a related production facility for $635 million, the companies said today, as the seller prepares to spin out its biopharma business as part of a plan ... [Published Genetic Engineering News - Jul 30 2014]

Quotes

"So it was pretty clear (from the evidence) that for vaccine-naïve people who had not received Pneumovax, getting this vaccine significantly decreased their risk of serious illness" Loehr said
...health problem, causing significant illness and mortality in older adults," said Dr Emilio A Emini, senior vice president, Vaccine R&D, Pfizer. "The results of the Community-Acquired Pneumonia Trial in Adults study underscore the potential benefits of Prevenar 13 in preventing disease in this age group."
...pneumonia is the most common type of community-acquired bacterial pneumonia in the U S Susan Silbermann, President, Pfizer Vaccines, said, "As health care professionals in the US begin to implement this new ACIP recommendation, we believe that Prevnar 13 can now help prevent vaccine-type pneumococcal pneumonia in older adults and has the potential to provide an important public healthhealth benefit. Pfizer remains committed to working with the healthcare and public health communities to raise awareness of the importance of adult immunization among consumers." The full research reports on Pfizer are available to download free of charge at:
...” Pfizer vaccines president Susan Silbermann said. "Pfizer remains committed to working with the healthcare and public health communities to raise awareness of the importance of adult immunization among consumers.”"

More Content

All (116) | News (94) | Reports (0) | Blogs (22) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Acip Votes to Recommend Pcv13 for Adults Aged 6... [Published HighBeam Research - 17 hours ago]
Does Pfizer still need AstraZeneca's vaccines b... [Published FierceVaccines - 21 hours ago]
ACIP Recommends Routine PCV13 Immunization for ... [Published American Family Physician - Aug 28 2014]
ACIP votes to recommend PCV13 for adults aged 6... [Published Pharmacist.com - Aug 26 2014]
Pfizer receives EMA acceptance for expanded ind... [Published Individual.com - Aug 23 2014]
Pertussis vaccination rates unchanged after epi... [Published Orthopedics Today - Aug 22 2014]
PREVNAR 13 (Pneumococcal 13-Valent Conjugate Va... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Technical Updates, Drug Recommendations, and Up... [Published TickerTech.com - Aug 19 2014]
A new, effective pneumonia vaccine gets the gre... [Published American Council On Science & Health - Aug 18 2014]
Stock Update (NYSE:PFE): Pfizer Announces Submi... [Published Jutia Group - Aug 18 2014]
Study: Digoxin increases death risk in AFIB pat... [Published Drugtopics.com - Aug 16 2014]
News Scan for Aug 15, 2014 [Published Centre For Infectious Disease Research and Policy - Aug 16 2014]
CDC committee recommends Pfizer pneumonia vacci... [Published Drug Store News - Aug 15 2014]
FDA sets decision date for Pfizer's MenB candidate [Published FierceVaccines - Aug 15 2014]
ACIP Backs Prevnar 13 for Seniors [Published MedPageToday.com - medical news plus CME for ph ... - Aug 15 2014]
US panel backs pneumococcal vaccines for seniors [Published PMLive - Aug 15 2014]
Pfizer’s Prevnar 13 Could See a $2 Billion Boos... [Published BioPortfolio - Aug 15 2014]
Global Biological Drugs Market 2014 - 2020 - In... [Published Individual.com - Aug 15 2014]
Endorsement could boost Pfizer vax [Published Medical Marketing And Media - Aug 15 2014]
Pfizer's Prevnar 13 Backed by U.S. Panel for Ex... [Published Zacks.com - Aug 14 2014]
Pfizer's Prevnar gets $2B boost with CDC nod in... [Published FierceVaccines - Aug 14 2014]
Pfizer's Prevnar 13 Backed by U.S. Panel for Ex... [Published Yahoo! Finance - Aug 14 2014]
Pfizer and Merck Receive Key Regulatory Approvals [Published TheStreet.com - Aug 14 2014]
CDC Advisors Recommend Prevnar 13 Vaccine for O... [Published P&T Community - Aug 14 2014]
Pfizer, Merck, pick up hefty vax sales bump wit... [Published FiercePharma - Aug 14 2014]
ACIP recommends Pfizer’s Prevnar 13 to treat pn... [Published Pharmaceutical Technology - Aug 14 2014]
CDC Recommends Pfizer’s Prevnar 13® Vaccine in ... [Published PharmaceuticalProcessing - Aug 14 2014]
CDC advisory panel recommends Pfizer's Prevnar ... [Published FirstWord Pharma - Aug 14 2014]
Medical Advisory Panel Recommends New Pneumonia... [Published Kaiser Health News - Aug 14 2014]
Why Pfizer (PFE) Stock Is Up Today [Published The Street Latest - Aug 14 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
PREVNAR 13 (Pneumococcal 13-Valent Conjugate Va... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 13, 2014 EST ...
ACIP Backs Prevnar 13 for Seniors [Published MedPageToday.com - medical news plus CME for ph ... - Aug 15 2014]
(MedPage Today) -- A conjugate vaccine against pneumococcus should be routinely used by people 65 and older, the CDC's Advisory Committee on Immunization Practices has recommended. ...
Advisory Committee on Immunization Practices Vo... [Published EON Consumer - Aug 13 2014]
NEW YORK--(EON: Enhanced Online News)--Pfizer Inc. (NYSE:PFE) today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13® (Pneumococcal 13-valent Conjugate ...
Advisory Committee on Immunization Practices Vo... [Published Business Wire Health News - Aug 13 2014]
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine ...
European Medicines Agency Accepts Application S... [Published Business Wire Health News - Aug 07 2014]
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the European Medicines Agency (EMA) has accepted Pfizer’s application seeking to expand the indication for Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) ...
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.